Director of the Gamaleya Research Center in Russia Alexander Ginstburg said that the center has developed a vaccine that protects against Delta and Omicron variants of COVID-19, RIA Novosti reported on Saturday. The new vaccine is based on the Russian Sputnik V jab and the clinical trials are...
The Russian Health Ministry has granted the Gamaleya Research Institute's vaccine against COVID-19 Sputnik V a permanent authorization, its head Mikhail Murashko told reporters on Friday.
The minister explained the treatment was previously "registered under preliminary conditions" and has now...
The Russian Direct Investment Fund (RDIF) said on Thursday that the Sputnik V coronavirus vaccine offers much higher protection against the Omicron variant than the Pfizer/BioNTech jab.
Citing comparative research at the Italian National Institute of Infectious Diseases Lazzaro Spallanzani, the RDIF...
Director of Gamaleya Research Institute of Epidemiology and Microbiology Alexander Gunzburg said on Tuesday that the efficacy of the Sputnik V vaccine against Omicron is about 75%.
According to the figures mentioned by Gunzburg during the XVI International Congress of Reproductive...
Gamaleya Research Institute Deputy Head Denis Logunov stated on Tuesday that the European Medicines Agency (EMA) has given "positive" feedback on the production standards of the former institution's vaccine against COVID-19, Sputnik V.
Logunov also told Soloviev Live that the institute, on the...
Russia's Gamaleya National Research Center of Epidemiology and Microbiology said on Wednesday that the Sputnik coronavirus nasal vaccine will target the virus' Omicron variant and reach the markets as soon as the first quarter or 2022.
"Sputnik nasal vaccine will be especially effective against highly...
Russia President Vladimir Putin asserted on Tuesday that the Sputnik V COVID-19 vaccine "definitely neutralizes" the Omicron coronavirus variant.
At an informal meeting of the Commonwealth of Independent States, Putin said that the research conducted by the Gamaleya Research Institute concluded...
Sputnik V coronavirus vaccine, followed by a Sputnik Light booster dose, provides "full protection" against the COVID-19 Omicron strain, Gamaleya Research Institute of Epidemiology and Microbiology Director Alexander Gintsburg said on Friday.
The effectiveness of the vaccine has been estimated...
Coronavirus vaccines developed by Johnson & Johnson and Sinopharm, as well as Russia's Sputnik V jab, produced almost no neutralizing activity against the Omicron variant, a study conducted by the University of Washington and Swiss drugmaker Humabs Biomed SA showed on Friday.
In a preprint...
Russian President Vladimir Putin and his Chinese counterpart Xi Jinping stressed on Wednesday at the beginning of their video call that the relations between Moscow and Beijing represent a real model of 21st-century bilateral cooperation.
Putin pointed out that trade exchange between their two...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
